Great MedTech does not win because it exists. It wins when the market understands it, trusts it, and adopts it.
At BMMG, we call our approach Engineering Adoption™: preparing the market and the care environment for a new technology’s successful introduction and sustained use. Before launch, we help clients bring together the clinical evidence supporting safety and efficacy, translate user feedback into credible peer-to-peer education, assess how the technology fits into existing clinical workflows, clarify reimbursement pathways and appropriate billing and coding, and quantify its economic impact, from initial investment through the total cost of ownership. We turn these insights into practical strategies and materials that address adoption barriers, build confidence among clinicians and decision makers, and improve the likelihood of market acceptance.
We are not here to simply make materials. We help clients make better commercialization decisions, avoid costly missteps, and build the clarity, confidence, and momentum required for adoption.
Great MedTech does not win because it exists. It wins when the market understands it, trusts it, and adopts it.
At BMMG, we call our approach Engineering Adoption™: preparing the market and the care environment for a new technology’s successful introduction and sustained use. Before launch, we help clients bring together the clinical evidence supporting safety and efficacy, translate user feedback into credible peer-to-peer education, assess how the technology fits into existing clinical workflows, clarify reimbursement pathways and appropriate billing and coding, and quantify its economic impact, from initial investment through the total cost of ownership. We turn these insights into practical strategies and materials that address adoption barriers, build confidence among clinicians and decision makers, and improve the likelihood of market acceptance.
We are not here to simply make materials. We help clients make better commercialization decisions, avoid costly missteps, and build the clarity, confidence, and momentum required for adoption.
Position your technology for the market realities that matter: clinical value, economic impact, stakeholder adoption, and growth-stage readiness.
Translate complex science, clinical evidence, and product differentiation into clear messages for physicians, hospitals, payers, investors, distributors, and patients.
Deploy the right mix of PR, KOL engagement, sales enablement, events, ABM, digital, and outreach—coordinated around market traction, not disconnected tactics.
BMMG is not a traditional agency. We are a commercialization partner for MedTech innovators navigating complex markets, clinical skepticism, regulatory boundaries, reimbursement pressures, and limited launch resources.
Our team brings decades of inside-the-industry experience across medical devices, diagnostics, biotech, provider organizations, PR, events, sales enablement, reimbursement, and strategic communications. We help clients avoid costly missteps, clarify their value, and build the market confidence required for adoption.
LEARN MORE
Some agencies put all their efforts into the creative appearance of materials and catchy phrases. We prefer to focus on overcoming clients’ challenges and achieving outstanding results.
From building an effective launch plan based on marketing strategies that accelerate customers’ awareness and lead to meaningful interactions, we judge our talents on how well we grasped the client’s
opportunities and brought solid solutions to the table.
Creating Market Readiness Before Clearance
BMMG helps MedTech innovators clarify their story, define priority audiences, and build credibility before launch—so the market is better prepared to understand, trust, and adopt what is coming.
Watch Video
Translating Clinical Value for Hospital Decision-Makers
BMMG connects clinical differentiation to the priorities of hospital executives, administrators, value analysis teams, payers, and commercial partners— turning product value into stakeholder relevance.
Watch Video
Equipping Commercial Teams to Drive Adoption
BMMG develops the messaging, sales tools, KOL engagement, event strategy, and campaign support commercial teams need to move prospects from awareness to action. Watch our webinar focused on driving adoption:
Watch Video
BMMG’s founder, Lisa Bichsel, literally wrote the book on launching medical devices. Click here to read more about her book and how to get your copy!
Bichsel Medical Marketing Group has been named a 2026 GPMG Global 100 Awards recipient, recognizing organizations demonstrating leadership, innovation, and impact in business. Bichsel Medical Marketing Group has also been recognized as one of the Top Healthcare Marketing Consulting/Service Companies in the country and one of the 50 fastest growing companies in 2021.
Successful companies are quantifying financial impact and preparing for multi-stakeholder sales